Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $84,418 | 1 | 96.3% |
| Food and Beverage | $3,202 | 193 | 3.7% |
| Education | $6.36 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $84,418 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $554.98 | 29 | $0 (2024) |
| Lundbeck LLC | $550.04 | 32 | $0 (2024) |
| ABBVIE INC. | $288.32 | 21 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $190.06 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $183.97 | 11 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $152.91 | 12 | $0 (2024) |
| Allergan, Inc. | $133.73 | 9 | $0 (2020) |
| Alkermes, Inc. | $128.55 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $127.01 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84,870 | 30 | Neuronetics, Inc. ($84,418) |
| 2023 | $339.69 | 20 | Otsuka America Pharmaceutical, Inc. ($70.32) |
| 2022 | $668.23 | 35 | ABBVIE INC. ($129.59) |
| 2021 | $437.43 | 29 | AbbVie Inc. ($142.42) |
| 2020 | $229.00 | 15 | Eisai Inc. ($59.60) |
| 2019 | $140.86 | 11 | Indivior Inc. ($39.09) |
| 2018 | $438.58 | 23 | Otsuka America Pharmaceutical, Inc. ($173.73) |
| 2017 | $502.57 | 33 | Otsuka America Pharmaceutical, Inc. ($162.56) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.33 | General |
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Debt forgiveness | Cash or cash equivalent | $84,418.03 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 09/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Neuropsychiatry | ||||||
| 06/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: PSYCHIATRY | ||||||
| 03/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 177 | 1,008 | $267,345 | $83,757 |
| 2022 | 3 | 160 | 1,127 | $299,000 | $96,845 |
| 2021 | 5 | 212 | 1,173 | $311,355 | $102,464 |
| 2020 | 5 | 322 | 1,332 | $353,580 | $91,777 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 932 | $246,980 | $78,648 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 43 | $11,395 | $2,798 | 24.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 15 | 15 | $4,200 | $1,510 | 36.0% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 13 | 18 | $4,770 | $800.56 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 1,086 | $287,790 | $93,102 | 32.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 23 | 23 | $6,440 | $2,652 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 18 | $4,770 | $1,090 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 1,058 | $280,370 | $93,842 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 51 | $13,515 | $3,072 | 22.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 14 | 30 | $7,950 | $2,071 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $4,480 | $1,840 | 41.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $5,040 | $1,638 | 32.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 987 | $261,555 | $73,410 | 28.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 225 | $59,625 | $9,765 | 16.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 40 | 40 | $11,200 | $3,746 | 33.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 29 | 47 | $12,455 | $3,067 | 24.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 26 | 33 | $8,745 | $1,788 | 20.5% |
About Dr. Ronnie Blount, M.D
Dr. Ronnie Blount, M.D is a Psychiatry healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720159098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronnie Blount, M.D has received a total of $87,626 in payments from pharmaceutical and medical device companies, with $84,870 received in 2024. These payments were reported across 196 transactions from 29 companies. The most common payment nature is "Debt forgiveness" ($84,418).
As a Medicare-enrolled provider, Blount has provided services to 871 Medicare beneficiaries, totaling 4,640 services with total Medicare billing of $374,843. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Behavior Analyst
- Location Macon, GA
- Active Since 11/10/2006
- Last Updated 04/23/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720159098
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $84,418
- REXULTI (Drug) $955.79
- VRAYLAR (Drug) $406.94
- CAPLYTA (Drug) $255.94
- AUSTEDO (Drug) $171.44
- TRINTELLIX (Drug) $162.70
- ABILIFY MAINTENA (Drug) $149.23
- ARISTADA (Drug) $128.55
- INGREZZA (Drug) $109.40
- INVEGA SUSTENNA (Drug) $105.45
- BELSOMRA (Drug) $91.97
- Dayvigo (Drug) $88.10
- QUVIVIQ (Drug) $87.12
- Wakix (Drug) $71.41
- SUBLOCADE (Drug) $67.93
- LATUDA (Drug) $57.20
- Trintellix (Drug) $32.62
- SUBOXONE SUBLINGUAL FILM (Drug) $30.66
- Probuphine (Drug) $29.11
- Zubsolv (Drug) $28.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Macon
Angela Eubanks, Msn, Pmhnp-Bc, MSN, PMHNP-BC
Psychiatry — Payments: $29,052
Angela Hale, M.d, M.D
Psychiatry — Payments: $5,768
Dr. Sujatha Reddy, M.d, M.D
Psychiatry — Payments: $5,012
Dr. Sarah Graff, Md, MD
Psychiatry — Payments: $3,311
Jacob Hanna, Md, MD
Psychiatry — Payments: $1,544
Dwight Bearden, Md, MD
Psychiatry — Payments: $1,292